<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02376491</url>
  </required_header>
  <id_info>
    <org_study_id>RC14_0375</org_study_id>
    <nct_id>NCT02376491</nct_id>
  </id_info>
  <brief_title>Efficacy of Intermittent ThetaBurst Stimulation Compared to 10 Hz Stimulation on Dorsolateral Prefrontal Cortex in Treatment Resistant Major Depressive Disorder: a Double-blind Randomized Study</brief_title>
  <acronym>THETA-DEP</acronym>
  <official_title>Efficacy of Intermittent ThetaBurst Stimulation Compared to 10 Hz Stimulation on Dorsolateral Prefrontal Cortex in Treatment Resistant Major Depressive Disorder: a Double-blind Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial will compare innovating stimulation parameters, intermittent Theta Burst
      Stimulation, to the standard high frequency stimulation protocol. The Left dorsolateral
      prefrontal cortex, targeted by MRI navigation will be the site of stimulation in both
      treatment conditions. The study seeks to determine if there is a superiority in therapeutic
      efficacy with iTBS protocol compared to conventional one.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Therapeutic response rate</measure>
    <time_frame>6 months</time_frame>
    <description>Primary outcome will be therapeutic response rate corresponding to with MADRS score improvement &gt; 50 % in each group at the end of TMS sessions and one month after.
A final score of &lt;8 is categorized as remission.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Relapse rate</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measures of cortical excitability</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>DEPRESSION</condition>
  <arm_group>
    <arm_group_label>High Frequency Left repetitive</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High Frequency Left repetitive transcranial magnetic stimulation five days per week for 4 weeks Magventure Cool B65 Coil with Magpro X100</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intermittent Theta Burst Stimulation (iTBS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intermittent Theta Burst Stimulation (iTBS) five days per week for 4 weeks Magventure Cool B65 Coil with Magpro X100</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial magnetic stimulation</intervention_name>
    <arm_group_label>High Frequency Left repetitive</arm_group_label>
    <arm_group_label>intermittent Theta Burst Stimulation (iTBS)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years to 75 years

          -  Both gender eligible

          -  Volontary and able to give consent

          -  Major depressive episode (MADRS &gt; 20) single or recurrent

          -  Resistance to at least 2 antidepressants ,

          -  Treated by antidepressant at efficient stable posology since more than 6 weeks

        Exclusion Criteria:

          -  Initiation or modification of antidepressant drug

          -  Neurodegenerative diseas

          -  Bipolar I, II disorder

          -  Schizophrenia, schizoaffective disorder, schizophreniform, delusional disorder, or
             current psychotic symptoms

          -  Substance abuse in past 15 days

          -  Substance dependence not weaned

          -  Benzodiazepine and any anticonvulsant during rTMS treatment course

          -  ECT failure in medical history

          -  Contra-indication to rTMS and MRI

          -  Pregnancy

          -  Difficulty to obtain informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samuel Bulteau, dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>chu de Nantes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Samuel Bulteau, dr</last_name>
    <phone>02 40 84 61 16</phone>
    <email>samuel.bulteau@chu-nantes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samuel BULTEAU</last_name>
    </contact>
    <investigator>
      <last_name>Samuel BULTEAU</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 17, 2015</study_first_submitted>
  <study_first_submitted_qc>February 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2015</study_first_posted>
  <last_update_submitted>May 18, 2017</last_update_submitted>
  <last_update_submitted_qc>May 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

